Analyst Observations
Published: September 9, 2025
This content is for informational purposes only. This should not be construed as solicitation. The general public should consult their financial advisor for additional information related to investment decisions.
Comments include: ALB, IONS, NUE, & PBF.

 

ALB Albemarle Corp ($72.58) - Chemicals - ALB was down more than 11% on Tuesday and fell to a negative trend when it hit $73. The negative trend change will drop ALB to an unfavorable 2 for 5'er. From here, the next level of support sits at $65.
IONS Ionis Pharmaceuticals Inc. ($64.50) - Drugs - IONS inched up higher to break a double top at $63, marking its third consecutive buy signal and a new multi-year high. The 5 for 5'er shifted up from a 3 earlier this month after moving to an RS buy signal against both the market and its peers. Additionally, the stock ranks second in the drugs sector matrix. The weekly OBOS indicates that the stock is in heavily overbought territory, so wait for the 10-week trading band to normalize before considering. Initial support is at $59, with additional support at $41.
NUE Nucor Corporation ($141.02) - Steel/Iron - NUE fell to a sell signal Tuesday when it broke a triple bottom at $142. The weight of the evidence remains moderately positive as NUE is a 3 for 5'er and ranks in the top half of the steel/iron sector matrix. From here, the next level of support is NUE's trend line at $138; beyond that level further support can be found at $136, a level from which NUE rallied three times in July and August.
PBF PBF Energy Inc. ($30.14) - Oil Service - PBF returned to a positive trend on Tuesday when it broke a double top at $30. The positive trend change will promote PBF to a 5 for 5'er; the stock also ranks in the top quintile of the oil service sector matrix. Tuesday's move has pushed the stock into heavily overbought territory. From here, the first level of support sits at $22.
Back to report

DISCLOSURE

This report is for Internal Use Only and not for distribution to the public. While we make every effort to be free of errors in this report, it contains data obtained from other sources. We believe these sources to be reliable, but we cannot guarantee their accuracy. Investors who use options should read the Options Disclosure Document before making any particular investment decision. Officers or employees of this firm may now or in the future have a position in the stocks mentioned in this report. Dorsey, Wright is a Registered Investment Advisor with the U.S. Securities & Exchange Commission. Copies of Form ADV Part II are available upon request.
Equity prices provided by Thomson-Reuters. Cross Rate prices provided by Tenfore Systems. Option prices provided by OPRA
Copyright © 1995-2026 Dorsey, Wright & Associates, LLC.®
All quotes displayed are delayed 20 minutes
Disclaimer/Terms of Use/Copyright